NEW YORK, May 30, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding The Procter & Gamble Company (NYSE: PG), Kimberly-Clark Corp (NYSE: KMB), PVH Corp. (NYSE: PVH), Pilgrim's Pride Corporation (NASDAQ: PPC) and Flowers Foods, Inc. (NYSE: FLO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3125-100free.

The Procter & Gamble Company Analyst Notes
On May 23, 2014, The Procter & Gamble Company (P&G) reported that one of its brands, Charmin, has launched the Charmin Relief Project to bring consumers a better bathroom experience. P&G informed that based on the statistics revealed by the Don't Pee in the Sea Survey, the Company learned that 62% or two- thirds of beachgoers admit they pee in the sea, among which 48% say that they have done it more than once. The Company added that in line with Charmin Relief Project, Charmin is visiting beaches across the country and providing beachgoers with clean and fresh-smelling portable bathrooms stocked with amenities, attendants, and plenty of Ultra Soft and Ultra Strong Charmin toilet paper. Scott Mautz, Regional Brand Director, said, "No need for people to pee in the sea, with Charmin's upscale restrooms providing the comforts of home. This is one more way Charmin is fulfilling our mission to provide people with a more enjoyable go, anytime, anywhere." The full analyst notes on P&G are available to download free of charge at:

http://www.analystsreview.com/PG.pdf/Register

Kimberly-Clark Corp Analyst Notes
On May 27, 2014, Kimberly-Clark Health Care, a subsidiary of Kimberly-Clark Corp. (Kimberly-Clark), announced that it has been recognized with three national awards of excellence from Novation, a leading health care supply chain expertise, analytics, and contracting company, serving over 100,000 members of VHA, UHC, Children's Hospital Association and Provista, LLC. Kimberly-Clark reported that the awards the Company received include the National Surgical Supplier of the Year award for its outstanding efforts in working with hospital members served by Novation; the Strategic Commitment Award for the Company's participation across Novation's committed offerings which enable significant savings for VHA, UHC, Children's Hospital Association and Provista members; and the National Account Manager of the Year given to Brian Krajca, Kimberly-Clark Health Care's Senior National Account Manager. The full analyst notes on Kimberly-Clark are available to download free of charge at:

http://www.analystsreview.com/KMB.pdf/Register

PVH Corp. Analyst Notes
On May 19, 2014, PVH Corp. (PVH) announced that it will release its Q1 2014 earnings results on Wednesday, June 4, 2014, after the market closes. PVH reported that the Company will sponsor a conference call on Thursday, June 5, 2014, at 9:00 a.m. ET, which will be hosted by Chairman and CEO, Emanuel Chirico, and Executive Vice President and Chief Operating & Financial Officer, Michael Shaffer, to discuss the results. The Company added that the call will be broadcast live through its website, while a replay of the call will also be archived at the same website for 12 months. The full analyst notes on PVH are available to download free of charge at:

http://www.analystsreview.com/PVH.pdf/Register

Pilgrim's Pride Corporation Analyst Notes
On May 27, 2014, Pilgrim's Pride Corporation (Pilgrim's) announced that it has proposed to acquire The Hillshire Brands Company for $45.00 per share in cash, in a $6.4 billion transaction. Pilgrim's reported that this all-cash proposal provides Hillshire shareholders with superior alternative to Hillshire's pending acquisition of Pinnacle Foods Inc. (Pinnacle), which represents a 25% premium to the volume weighted average price of Hillshire shares over the ten trading days after the announcement of the transaction with Pinnacle. The Company added that the Board of Directors of Pilgrim's, as well as its majority owner JBS S.A., support the proposal which is anticipated to close in Q3 2014, subject to customary closing conditions and the termination of Hillshire and Pinnacle's merger agreement. The full analyst notes on Pilgrim's are available to download free of charge at:

http://www.analystsreview.com/PPC.pdf/Register

Flowers Foods, Inc. Analyst Notes
On May 21, 2014, the Board of Directors of Flowers Foods, Inc. (Flowers Foods) has declared a quarterly cash dividend of $0.12 per share, an increase of 6.7% over the previously paid dividend. According to the Company, the dividend is payable on June 18, 2014, to shareholders of record as on June 4, 2014. Flowers Foods reported that this action increases the annualized dividend rate to $0.48 per share. "In the first quarter of 2014, we again generated strong cash flow from operations, which allowed us to pay down $81.2 million in debt, pay $24 million in dividends to shareholders, invest $23.6 million in capital improvements, and acquire $9.5 million of FLO common stock as part of the stock repurchase plan," said Allen L. Shiver, President and CEO, Flowers Foods. "The board believes the dividend is an appropriate way to allow our investors to participate in the company's success." The full analyst notes on Flowers Foods are available to download free of charge at:

http://www.analystsreview.com/FLO.pdf/Register

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

EDITOR'S NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review